Evidence map›Paper›PMID 28913710›Full record

ArticleJournal of computer-aided molecular design2018

Performance of multiple docking and refinement methods in the pose prediction D3R prospective Grand Challenge 2016.

Xavier Fradera, Andreas Verras, Yuan Hu, Deping Wang, Hongwu Wang, James I Fells, Kira A Armacost, Alejandro Crespo, Brad Sherborne, Huijun Wang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xavier FraderaMerck & Co., Inc., 33 Avenue Louis Pasteur, Boston, MA, 02215, USA. xavier.fradera@merck.com.ORCID 0000-0001-5353-4784
Andreas VerrasMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA. Andreas.verras@merck.com.ORCID 0000-0002-6118-075X
Yuan HuMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA.ORCID 0000-0002-1014-6594
Deping WangMerck & Co., Inc., 770 Sumneytown Pike, West Point, PA, 19486, USA.
Hongwu WangMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA.
James I FellsMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA.
Kira A ArmacostMerck & Co., Inc., 770 Sumneytown Pike, West Point, PA, 19486, USA.
Alejandro CrespoMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA.
Brad SherborneMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA.
Huijun WangMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA.
Zhengwei PengMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA.
Ying-Duo GaoMerck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033-1310, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the performance of multiple pose prediction methods for the D3R 2016 Grand Challenge. The pose prediction challenge includes 36 ligands, which represent 4 chemotypes and some miscellaneous structures against the FXR ligand binding domain. In this study we use a mix of fully automated methods as well as human-guided methods with considerations of both the challenge data and publicly available data. The methods include ensemble docking, colony entropy pose prediction, target selection by molecular similarity, molecular dynamics guided pose refinement, and pose selection by visual inspection. We evaluated the success of our predictions by method, chemotype, and relevance of publicly available data. For the overall data set, ensemble docking, visual inspection, and molecular dynamics guided pose prediction performed the best with overall mean RMSDs of 2.4, 2.2, and 2.2 Å respectively. For several individual challenge molecules, the best performing method is evaluated in light of that particular ligand. We also describe the protein, ligand, and public information data preparations that are typical of our binding mode prediction workflow.

Indexed as

Computer-Aided DesignDrug DesignDrug DiscoveryMolecular Docking SimulationBinding SitesCrystallography, X-RayDatabases, ProteinHumansLigandsMolecular Dynamics SimulationProtein BindingProtein ConformationReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearThermodynamicsLigandsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearD3R Grand Challenge 2016DockingFXRMolecular dynamicsPose prediction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.